OMedLive

CME Presentations

Pediatric Neuroblastoma - Nursing Care


Presentations

  • CME
    1.0

    Optimal Nursing Strategies to Manage Pediatric Patients with High-Risk Neuroblastoma

    Speakers:Jennifer Saggio, MSN, CRNP, CPON, Neuroblastoma Nurse Practitoner
    Erin Armideo, CRNP, RN, CPON, Pediatric Oncology Nurse Pracitioner

    Duration: 60 minutes

    Presented on: August 4, 2017

  • CME
    1.0

    Recurrent/Refractory Disease of Pediatric Neuroblastoma: Enhancing the Role of the Nurse

    Speakers:Gregory C. Hedler, MSW, LCSW, Social Worker, Cancer Center
    Jennifer Saggio, MSN, CRNP, CPON, Neuroblastoma Nurse Practitoner

    Duration: 60 minutes

    Presented on: September 29, 2017


Speakers

  • Jennifer Saggio, MSN, CRNP, CPON

    Jennifer Saggio, MSN, CRNP, CPON

    Jennifer Saggio, MSN, CRNP, CPON

    Neuroblastoma Nurse Practitoner

    Jennifer Saggio, RN, MSN, CRNP, CPON, MSN, is a neuroblastoma nurse practitioner at The Children’s Hospital of Philadelphia (CHOP) in Pennsylvania, and has been a nurse practitioner in the Division of Oncology at CHOP for the past 18 years. Ms Saggio coordinates care for children with recurrent/refractory neuroblastoma, and provides consultations to physicians, nurses, and families in order to meet the complex needs of both hospitalized and ambulatory patients with neuroblastoma. Her team cares for patients who live in the Philadelphia region, those who travel from throughout the United States, and to a large population of international patients as well. She received her graduate degree from the Pediatric Acute/Chronic Care NP Program at the University of Pennsylvania in Philadelphia.
  • Erin Armideo, CRNP, RN, CPON

    Erin Armideo, CRNP, RN, CPON

    Erin Armideo, CRNP, RN, CPON

    Pediatric Oncology Nurse Pracitioner

    Erin Armideo, RN, MSN, CRNP, CPON, is a nurse practitioner at The Children’s Hospital of Philadelphia (CHOP) in Pennsylvania, where she began her career as a pediatric oncology nurse. She earned her bachelors of nursing from the Pennsylvania State University and a master’s degree in nursing from the University of Pennsylvania, Pediatric Acute Care Nurse Practitioner program. Ms Armideo has cared for patients with various types of solid tumors in both inpatient and outpatient settings. Her passion is educating patients and families about their child’s disease, treatment and side effects of treatment. She has presented in various forums, including internationally on the management of side effects related to immunotherapy, and has received awards from CHOP and the Philadelphia City Council.
  • Gregory C. Hedler, MSW, LCSW

    Gregory C. Hedler, MSW, LCSW

    Gregory C. Hedler, MSW, LCSW

    Social Worker, Cancer Center

    Gregory C. Hedler, MSW, LCSW, is a licensed clinical social worker at the Children’s Hospital of Philadelphia (CHOP) in Pennsylvania. Focusing his supportive efforts on newly diagnosed high-risk neuroblastoma, as well as relapsed or refractory neuroblastoma, he offers 13 years of experience in pediatric oncology to these patients and their families, tailoring his therapeutic interventions to meet the nuanced psychosocial needs associated with recurrent and refractory disease. Before joining CHOP, he worked at The Children's Cancer Institute at Hackensack University Medical Center in New Jersey, caring for patients with various types of childhood cancers as well as those with sickle cell disease. Mr Hedler received his master of social work from Fordham University in New York, New York.

CME Information

Advances in Nursing Care for Pediatric Patients with High-Risk Neuroblastoma

Jointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC

 
 

ACKNOWLEDGEMENT This activity is supported by an independent educational grant from United Therapeutics Corporation.

TUITION Complimentary

ACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS Live Internet Activity The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Enduring Material The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This educational activity for 2 contact hour(s) is provided by the Postgraduate Institute for Medicine.

DATE OF RELEASE/EXPIRATION Live Activity Session I: Optimal Nursing Strategies to Manage Pediatric Patients with High-Risk Neuroblastoma Friday, August 4, 2017 from 11:00am – 12:00pm EST. Session II: Recurrent/Refractory Disease of Pediatric Neuroblastoma: Enhancing the Role of the Nurse Friday, September 29, 2017 from 11:00am – 12:00pm EST. Enduring Material Session I: The enduring material will be available from August 4, 2017 – September 29, 2018. Session II: The enduring material will be available from September 29, 2017 — September 29, 2018.

LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to:

Review the fundamentals of diagnosing, treating, and managing high-risk pediatric neuroblastoma
Examine strategies to improve supportive care for children with high-risk neuroblastoma
Examine the aspects of parental decision-making regarding appropriate care for children with recurrent/refractory neuroblastoma
Plan strategies to improve the dialogue and working relationship with parents/caregivers of pediatric patients regarding the goals of care through the treatment continuum and beyond

Nursing Educational Objective

After completing this activity, the participant should be able to:

Provide appropriate care and counsel for patients and their families

TARGET AUDIENCE This activity is intended for pediatric oncology nurses, pediatric nurses, oncology nurses, nurse practitioners, nurse managers, infusion nurses, research nurses, physician assistants, and other health care providers who care for or have an interest in pediatric patients with high-risk neuroblastoma

ESTIMATED TIME TO COMPLETE This activity consists of two sessions which should take approximately 2 hours to complete.

METHOD OF PARTICIPATION There are no fees to participate in this activity. To participate in the activity, go to http://www.OMedLive.com/. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. It is estimated that this module will take approximately 1 hours to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE OF CONFLICTS OF INTEREST Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Jennifer Saggio, MSN, CRNP, CPON Neuroblastoma Developmental Therapeutics Advanced Practice Nurse Children's Hospital of Philadelphia  
Erin Armideo, MSN, CRNP, RN, CPON Nurse Practitioner, Cancer Center Children's Hospital of Philadelphia

Gregory C. Hedler, MSW, LCSW Social Worker Children's Hospital of Philadelphia

 

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner Reprted Financial Relationship
Hamsa Jaganathan, PhD Medical Director PlatformQ Health Education, LLC None

The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable): This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION Accreditation Support: Please contact the Postgraduate Institute for Medicine at www.pimed.com.

Technical Support: For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com.